Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason N Cole

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Journal of Molecular Medicine (Berlin, Germany)|April 25, 2012
Conserved anchorless surface proteins as group A streptococcal vaccine candidatesAnna Henningham, Emiliano Chiarot, Christine M Gillen, et al.
The Journal of Biological Chemistry|October 1, 2014
Mutual exclusivity of hyaluronan and hyaluronidase in invasive group A StreptococcusAnna Henningham, Masaya Yamaguchi, Ramy K Aziz, et al.
Journal of Innate Immunity|September 4, 2010
Parameters governing invasive disease propensity of non-M1 serotype group A streptococciPeter G Maamary, Martina L Sanderson-Smith, Ramy K Aziz, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 11, 2012
Tracing the evolutionary history of the pandemic group A streptococcal M1T1 clonePeter G Maamary, Nouri L Ben Zakour, Jason N Cole, et al.
Nature Microbiology|March 18, 2025
Drug-Fc conjugate CD388 targets influenza virus neuraminidase and is broadly protective in miceSimon Döhrmann, James Levin, Jason N Cole, et al.
Cell Host & Microbe|June 13, 2014
The classical lancefield antigen of group a Streptococcus is a virulence determinant with implications for vaccine designNina M van Sorge, Jason N Cole, Kirsten Kuipers, et al.
Nature Communications|March 19, 2023
Integrative omics identifies conserved and pathogen-specific responses of sepsis-causing bacteriaAndre Mu, William P Klare, Sarah L Baines, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Journal of Molecular Medicine (Berlin, Germany)|April 25, 2012
Conserved anchorless surface proteins as group A streptococcal vaccine candidatesAnna Henningham, Emiliano Chiarot, Christine M Gillen, et al.
The Journal of Biological Chemistry|October 1, 2014
Mutual exclusivity of hyaluronan and hyaluronidase in invasive group A StreptococcusAnna Henningham, Masaya Yamaguchi, Ramy K Aziz, et al.
Journal of Innate Immunity|September 4, 2010
Parameters governing invasive disease propensity of non-M1 serotype group A streptococciPeter G Maamary, Martina L Sanderson-Smith, Ramy K Aziz, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 11, 2012
Tracing the evolutionary history of the pandemic group A streptococcal M1T1 clonePeter G Maamary, Nouri L Ben Zakour, Jason N Cole, et al.
Nature Microbiology|March 18, 2025
Drug-Fc conjugate CD388 targets influenza virus neuraminidase and is broadly protective in miceSimon Döhrmann, James Levin, Jason N Cole, et al.
Cell Host & Microbe|June 13, 2014
The classical lancefield antigen of group a Streptococcus is a virulence determinant with implications for vaccine designNina M van Sorge, Jason N Cole, Kirsten Kuipers, et al.
Nature Communications|March 19, 2023
Integrative omics identifies conserved and pathogen-specific responses of sepsis-causing bacteriaAndre Mu, William P Klare, Sarah L Baines, et al.
Pageof 4